PT Sinar Mas Multiartha Tbk (ISX:SMMA) Research & Development: Rp0 Mil (TTM As of Sep. 2025)


ISX:SMMA PT Sinar Mas Multiartha Tbk ISX:SMMA
56 GF Score
Price Rp21,875.00
GF Value Rp17,058.21
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is PT Sinar Mas Multiartha Tbk Research & Development?

PT Sinar Mas Multiartha Tbk ISX:SMMA 56 Research & Development is Rp0 Mil as of Sep. 2025. GuruFocus rates ISX:SMMA with a GF Score™ of 56/100 and a GF Value™ of Rp17,058.21 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PT Sinar Mas Multiartha Tbk's Research & Development for the three months ended in Sep. 2025 was Rp0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 was Rp0 Mil.

PT Sinar Mas Multiartha Tbk  (ISX:SMMA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PT Sinar Mas Multiartha Tbk Research & Development Related Terms

PT Sinar Mas Multiartha Tbk Research & Development Historical Data

* Premium members only.

The historical data trend for PT Sinar Mas Multiartha Tbk's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Sinar Mas Multiartha Tbk Research & Development Chart

PT Sinar Mas Multiartha Tbk Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PT Sinar Mas Multiartha Tbk Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ISX:SMMA
56GF Score
PT Sinar Mas Multiartha Tbk ISX:SMMA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Sinar Mas Multiartha Tbk Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of Rp0 Mil mean?
PT Sinar Mas Multiartha Tbk (ISX:SMMA) has a Research & Development of Rp0 Mil as of Sep. 2025. Research and development expense is the total cost for research and development activities. View historical data on PT Sinar Mas Multiartha Tbk and its competitors.
Is PT Sinar Mas Multiartha Tbk's Research & Development too high?
PT Sinar Mas Multiartha Tbk's current Research & Development is Rp0 Mil. Overall, PT Sinar Mas Multiartha Tbk has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Sinar Mas Multiartha Tbk's Research & Development compare to BRK.A and AIG?
PT Sinar Mas Multiartha Tbk's Research & Development of Rp0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PT Sinar Mas Multiartha Tbk and its competitors. PT Sinar Mas Multiartha Tbk's current Research & Development is Rp0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Sinar Mas Multiartha Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Sinar Mas Multiartha Tbk (ISX:SMMA) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp17,058.21, compared to a current price of Rp21,875.00 — trading 28.2% above its estimated fair value. The current Research & Development is Rp0 Mil. PT Sinar Mas Multiartha Tbk's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PT Sinar Mas Multiartha Tbk (ISX:SMMA), the current Research & Development is Rp0 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Sinar Mas Multiartha Tbk (ISX:SMMA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Sinar Mas Multiartha Tbk stock appears to be overvalued. The current stock price of Rp21,875.00 is trading 28.2% above its estimated GF Value™ of Rp17,058.21. GuruFocus considers PT Sinar Mas Multiartha Tbk to be Modestly Overvalued.

Key valuation signals for ISX:SMMA:

  • Research & Development: Rp0 Mil
  • GF Value™: Rp17,058.21 vs. price of Rp21,875.00 (28.2% above fair value)
  • GF Score™: 56/100 with 6 warning signs

No single metric tells the full story. See the ISX:SMMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Sinar Mas Multiartha Tbk Business Description

Address Sinar Mas Land Plaza, Tower I Lt 1 dan 2, Jl. MH Thamrin No. 51, Jakarta, IDN, 10350
PT Sinar Mas Multiartha Tbk provides an integrated and comprehensive range of financial services in Indonesia. The company is engaged in insurance underwriting, consumer financing, factoring of accounts, securities administration, securities brokerage, investment management, banking, development, Information technology, trading, and other related services. It is also involved in the auction house, property, health clinic, and workshop activities.
56GF Score

Get the complete analysis for ISX:SMMA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp21,875.00
Price
Rp17,058.21
GF Value